Modus Therapeutics Holding AB (publ) (MODTX.ST)

SEK 1.89

(-5.04%)

Eps Summary of Modus Therapeutics Holding AB (publ)

  • Modus Therapeutics Holding AB (publ)'s latest annual eps in 2023 was -1.01 SEK , up 11.4% from previous year.
  • Modus Therapeutics Holding AB (publ)'s latest quarterly eps in 2024 Q2 was -0.13 SEK , down -44.44% from previous quarter.
  • Modus Therapeutics Holding AB (publ) reported an annual eps of -1.14 SEK in 2022, up 31.74% from previous year.
  • Modus Therapeutics Holding AB (publ) reported an annual eps of -1.67 SEK in 2021, down -351.35% from previous year.
  • Modus Therapeutics Holding AB (publ) reported a quarterly eps of -0.09 SEK for 2024 Q1, up 50.0% from previous quarter.
  • Modus Therapeutics Holding AB (publ) reported a quarterly eps of -1.10 SEK for 2023 Q1, down -89.66% from previous quarter.

Annual Eps Chart of Modus Therapeutics Holding AB (publ) (2023 - 2018)

Historical Annual Eps of Modus Therapeutics Holding AB (publ) (2023 - 2018)

Year Eps Eps Growth
2023 -1.01 SEK 11.4%
2022 -1.14 SEK 31.74%
2021 -1.67 SEK -351.35%
2020 -0.37 SEK 86.35%
2019 -2.71 SEK 12.01%
2018 -3.08 SEK 0.0%

Peer Eps Comparison of Modus Therapeutics Holding AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -83.636%
Ziccum AB (publ) -1.54 SEK 34.416%
BioArctic AB (publ) 2.60 SEK 138.846%
Sprint Bioscience AB (publ) -0.01 SEK -15931.746%
Mendus AB (publ) -4.40 SEK 77.045%
Genovis AB (publ.) 0.94 SEK 207.447%
Intervacc AB (publ) -1.69 SEK 40.237%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -359.091%
Active Biotech AB (publ) -0.17 SEK -494.118%
Magle Chemoswed Holding AB (publ) 1.13 SEK 189.381%
Bio-Works Technologies AB (publ) -1.57 SEK 35.669%
Aptahem AB (publ) -0.05 SEK -1991.097%
Vicore Pharma Holding AB (publ) -3.22 SEK 68.634%
Kancera AB (publ) -0.80 SEK -26.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 89.849%
Fluicell AB (publ) -0.24 SEK -320.833%
Saniona AB (publ) -1.29 SEK 21.705%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -431.579%
Biovica International AB (publ) -2.14 SEK 52.804%
Spago Nanomedical AB (publ) -0.43 SEK -134.884%
AcouSort AB (publ) -1.29 SEK 21.705%
Xintela AB (publ) -0.13 SEK -676.923%
Abliva AB (publ) -0.09 SEK -1017.257%
Egetis Therapeutics AB (publ) -1.27 SEK 20.472%
Karolinska Development AB (publ) 0.02 SEK 5150.0%
OncoZenge AB (publ) -1.36 SEK 25.735%
Amniotics AB (publ) -0.01 SEK -9081.818%
2cureX AB (publ) -1.85 SEK 45.405%
CombiGene AB (publ) -1.80 SEK 43.889%
Asarina Pharma AB (publ) -0.57 SEK -77.193%
Calliditas Therapeutics AB (publ) -8.69 SEK 88.377%
Camurus AB (publ) 7.78 SEK 112.982%
Corline Biomedical AB -0.08 SEK -1099.525%
IRLAB Therapeutics AB (publ) -3.43 SEK 70.554%
Isofol Medical AB (publ) -0.23 SEK -339.13%
I-Tech AB 1.70 SEK 159.412%
Hansa Biopharma AB (publ) -15.83 SEK 93.62%
Cyxone AB (publ) -0.22 SEK -359.091%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 48.99%
Biosergen AB -0.60 SEK -68.333%
Cantargia AB (publ) -1.65 SEK 38.788%
NextCell Pharma AB -1.03 SEK 1.942%
Xspray Pharma AB (publ) -6.76 SEK 85.059%
Elicera Therapeutics AB (publ) -0.83 SEK -21.687%
Nanologica AB (publ) -2.05 SEK 50.732%
SynAct Pharma AB -6.64 SEK 84.789%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -288.462%
Stayble Therapeutics AB (publ) -0.92 SEK -9.783%
LIDDS AB (publ) -0.63 SEK -60.317%
Lipum AB (publ) -4.45 SEK 77.303%
BioInvent International AB (publ) -5.02 SEK 79.88%
Alzinova AB (publ) -0.41 SEK -146.341%
Oncopeptides AB (publ) -1.96 SEK 48.469%
Pila Pharma AB (publ) -0.47 SEK -114.894%
Guard Therapeutics International AB (publ) -11.26 SEK 91.03%
Scandinavian ChemoTech AB (publ) -1.13 SEK 10.619%
Simris Alg AB (publ) -0.16 SEK -531.25%
Diamyd Medical AB (publ) -1.60 SEK 36.875%
Xbrane Biopharma AB (publ) -1.27 SEK 20.472%
Ascelia Pharma AB (publ) -3.24 SEK 68.827%
Diagonal Bio AB (publ) -0.32 SEK -215.625%